Metabolomics-assisted evaluation of differences and clinical value between ablation and surgical treatment for lung adenocarcinoma - Top-Institutions - MDSpire

Metabolomics-assisted evaluation of differences and clinical value between ablation and surgical treatment for lung adenocarcinoma

  • By

  • Youli Wen

  • Yang Zeng

  • Wenqiang Li

  • Xinyu Deng

  • Wu Qunhua

  • Zhiping Deng

  • July 16, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University Hospital
    University Hospital

    Copenhagen, Denmark

    Key Differentiators

    • Oncology
    • Surgery

  • #2

    Bergonié Institute
    Bergonié Institute

    Bordeaux, France

    Key Differentiators

    • Oncology

  • #3

    RWTH Aachen University
    RWTH Aachen University

    Aachen, Germany

    Key Differentiators

    • Oncology
    • Surgery

Original Source(s)

Metabolomics-assisted evaluation of differences and clinical value between ablation and surgical treatment for lung adenocarcinoma

  • by Youli Wen, Yang Zeng, Wenqiang Li, Xinyu Deng, Wu Qunhua, Zhiping Deng

  • July 16, 2026

Related Content

Correction: DPCrossU-Net: a dual-branch parallel CNN–Transformer network for lung nodule segmentation

Surfactant protein D: prognostic insights and emerging therapeutic roles in cancer

Translating physical stress into biological signals: precision electro-oncology based on conformational changes of electro-sensitive receptors and parameterized immune remodeling